C J Carrera

2-Chlorodeoxyadenosine treatment of low-grade lymphomas.

Andrea Kay, Alan Saven, C J Carrera et al. · Journal of Clinical Oncology · 1992 · 169 citations

Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2‘,3‘-dideoxyadenosine derivatives.

Thomas Haertlé, C J Carrera, D B Wasson et al. · Journal of Biological Chemistry · 1988 · 128 citations · Full text

Bioorganic Chemistry, Biochemistry, 2-Halo-2',3'-dideoxyadenosine Derivatives +11

2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies.

Alan Saven, Hajime Kawasaki, C J Carrera et al. · Journal of Clinical Oncology · 1993 · 54 citations

Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia.

Michael W. DeGregorio, C J Carrera, John Klock et al. · PubMed · 1982 · 17 citations

Hematological Malignancy, Oncology, Plasma Kinetics +13

Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.

Dennis A. Carson, C J Carrera · PubMed · 1990 · 13 citations